TOLREMO therapeutics
Focused on the discovery and development of small molecules to prevent resistance in cancer therapy. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€114—171m (Dealroom.co estimates Sep 2023.)
Company register number CH-020.3.044.339-3
Basel Basel-City (HQ)
Authorizing premium user...